newsfilter
← Latest News
GlobeNewswire·

Ambrx Announces Closing of $75 Million Market Priced Registered Offering

SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (or the "Company") (NASDAQ:AMAM), today announced the closing of its previously announced market-priced registered direct offering of